Stay updated on Cardiac Benefits of Empagliflozin Clinical Trial
Sign up to get notified when there's something new on the Cardiac Benefits of Empagliflozin Clinical Trial page.

Latest updates to the Cardiac Benefits of Empagliflozin Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added and older notices about funding and operating status were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding notice about potential updates and the NIH Clinical Center's status. Updated the page revision to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a glossary display and updated QC metadata to show 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed the older QC label 'Last Update Submitted that met QC Criteria', the 'No FEAR Act data' label, and the previous revision 'v3.3.4'.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 appeared in the page footer replacing v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a Locations section featuring New York as a study site; removed the separate New York Locations item and the HHS Vulnerability Disclosure link from the footer.SummaryDifference0.2%

- Check85 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Cardiac Benefits of Empagliflozin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cardiac Benefits of Empagliflozin Clinical Trial page.